載入...
Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
BACKGROUND: Increased mineralocorticoid activity is one of the plausible causes of chronic central serous chorioretinopathy (CSCR) and mineralocorticoid inhibitors such as eplerenone have been investigated as its potential therapy. This study investigates the short-term safety and efficacy of oral e...
Na minha lista:
| 發表在: | Int J Retina Vitreous |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734298/ https://ncbi.nlm.nih.gov/pubmed/31516734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-019-0190-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|